These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38589351)

  • 1. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
    Maron BA; Wang RS; Shevtsov S; Drakos SG; Arons E; Wever-Pinzon O; Huggins GS; Samokhin AO; Oldham WM; Aguib Y; Yacoub MH; Rowin EJ; Maron BJ; Maron MS; Loscalzo J
    Nat Commun; 2024 Apr; 15(1):3038. PubMed ID: 38589351
    [No Abstract]   [Full Text] [Related]  

  • 2. Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
    Maron BA; Wang RS; Shevtsov S; Drakos SG; Arons E; Wever-Pinzon O; Huggins GS; Samokhin AO; Oldham WM; Aguib Y; Yacoub MH; Rowin EJ; Maron BJ; Maron MS; Loscalzo J
    Nat Commun; 2022 Nov; 13(1):7026. PubMed ID: 36396654
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
    Maron BA; Wang RS; Shevtsov S; Drakos SG; Arons E; Wever-Pinzon O; Huggins GS; Samokhin AO; Oldham WM; Aguib Y; Yacoub MH; Rowin EJ; Maron BJ; Maron MS; Loscalzo J
    Nat Commun; 2021 Feb; 12(1):873. PubMed ID: 33558530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance.
    Augusto JB; Davies RH; Bhuva AN; Knott KD; Seraphim A; Alfarih M; Lau C; Hughes RK; Lopes LR; Shiwani H; Treibel TA; Gerber BL; Hamilton-Craig C; Ntusi NAB; Pontone G; Desai MY; Greenwood JP; Swoboda PP; Captur G; Cavalcante J; Bucciarelli-Ducci C; Petersen SE; Schelbert E; Manisty C; Moon JC
    Lancet Digit Health; 2021 Jan; 3(1):e20-e28. PubMed ID: 33735065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized surgical strategies for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Collis R; Tsang V; Pantazis A; Tome-Esteban M; Elliott PM; McGregor CGA
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1237-1243. PubMed ID: 29293974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rediscovering the value of exercise in patients with hypertrophic cardiomyopathy.
    Liu L; Zhu J; Chen H; Hong L; Jiang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):758-764. PubMed ID: 36915972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.
    Wang RS; Rowin EJ; Maron BJ; Maron MS; Maron BA
    Cardiovasc Res; 2023 May; 119(3):e125-e127. PubMed ID: 37129987
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy.
    Butters A; Semsarian CR; Bagnall RD; Yeates L; Stafford F; Burns C; Semsarian C; Ingles J
    Circ Heart Fail; 2021 Mar; 14(3):e007537. PubMed ID: 33724884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy is associated with dilated sinus of Valsalva: A case-control study.
    Yoon JA; Ahmad MM; Husain A; Walson LA; Syed MN; Tajik AJ; Ammar KA
    Int J Cardiol Heart Vasc; 2023 Apr; 45():101180. PubMed ID: 36785849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a neural network to diagnose the hypertrophic portions of hypertrophic cardiomyopathy.
    Ouyang N; Yamauchi K
    MD Comput; 1998; 15(2):106-9. PubMed ID: 9540323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy.
    Subasic K
    Nurs Clin North Am; 2013 Dec; 48(4):571-84. PubMed ID: 24295188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
    Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S
    Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Author Correction: The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
    Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; Ben He
    Sci Rep; 2018 Aug; 8(1):12232. PubMed ID: 30097628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care.
    Parker LE; Landstrom AP
    Prog Pediatr Cardiol; 2021 Sep; 62():. PubMed ID: 34776723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice.
    Lawley CM; Kaski JP
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of established arrhythmogenic right ventricular cardiomyopathy mutation in a patient with the contrasting phenotype of hypertrophic cardiomyopathy.
    Bainbridge MN; Li L; Tan Y; Cheong BY; Marian AJ
    BMC Med Genet; 2017 Mar; 18(1):24. PubMed ID: 28253841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of three novel pathogenic mutations in sarcomere genes associated with familial hypertrophic cardiomyopathy based on multi-omics study.
    Liu W; Wei Z; Zhang Y; Liu Y; Bai R; Ma C; Yang J; Sun D
    Clin Chim Acta; 2021 Sep; 520():43-52. PubMed ID: 34087240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic approaches in hypertrophic cardiomyopathy: from symptom relief to precision therapy].
    Argirò A; Zampieri M; Marchi A; Del Franco A; Pàlinkàs ED; Biagioni G; Chiti C; Mazzoni C; Fornaro A; Targetti M; Cappelli F; Olivotto I
    G Ital Cardiol (Rome); 2023 Oct; 24(10):792-799. PubMed ID: 37767831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac magnetic resonance image diagnosis of hypertrophic obstructive cardiomyopathy based on a double-branch neural network.
    You Y; Viktorovich LA; Qiu J; Nikolaevich KA; Vladimirovich BY
    Comput Methods Programs Biomed; 2021 Mar; 200():105889. PubMed ID: 33293182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies: JACC Focus Seminar 3/5.
    Fatkin D; Calkins H; Elliott P; James CA; Peters S; Kovacic JC
    J Am Coll Cardiol; 2021 May; 77(20):2551-2572. PubMed ID: 34016267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.